• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
Generic Name:  tetracosactide hexaacetate (beta 1-24-corticotrophin)
Trade Name:  Synacthen Depot, S. Retard
Date Designated:  10/31/2012
Orphan Designation:  Treatment of infantile spasms
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Cerium Pharmaceuticals, Inc.
817-B Linsdale Street
Gaithersburg, Maryland 20878

The sponsor address listed is the last reported by the sponsor to OOPD.